Theralase Technologies Inc.
TLT.V
TSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -20.11% | 115.47% | -51.23% | 9.69% | 21.46% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -20.11% | 115.47% | -51.23% | 9.69% | 21.46% |
| Cost of Revenue | -17.96% | 37.15% | -35.43% | -0.85% | 3.19% |
| Gross Profit | -21.67% | 320.59% | -79.83% | 16.63% | 39.39% |
| SG&A Expenses | 3.63% | 6.58% | 1.09% | -0.52% | -0.41% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -0.69% | -4.75% | 2.36% | -4.84% | -1.80% |
| Operating Income | -6.39% | 15.39% | -9.75% | 10.13% | 8.21% |
| Income Before Tax | -6.88% | 16.95% | -9.11% | 9.95% | 9.22% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -6.88% | 16.95% | -9.11% | 9.95% | 9.22% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -6.88% | 16.95% | -9.11% | 9.95% | 9.22% |
| EBIT | -6.39% | 15.39% | -9.75% | 10.13% | 8.21% |
| EBITDA | -6.96% | 15.45% | -10.54% | 10.17% | 8.17% |
| EPS Basic | 0.00% | 22.22% | 0.00% | 18.75% | 17.14% |
| Normalized Basic EPS | 0.00% | 22.73% | 0.00% | 20.00% | 18.18% |
| EPS Diluted | 0.00% | 22.22% | 0.00% | 18.75% | 17.14% |
| Normalized Diluted EPS | 0.00% | 22.73% | 0.00% | 20.00% | 18.18% |
| Average Basic Shares Outstanding | 6.82% | 7.18% | 8.00% | 13.26% | 7.71% |
| Average Diluted Shares Outstanding | 6.82% | 7.18% | 8.00% | 13.26% | 7.71% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |